AzTrials
AzTrials

GI CancerPolypNCT06929117

Prevalence of Types and Patterns of Gastrointestinal Polyps in Assiut University Hospitals ( Cross Sectional Study

An observational study of GI Cancer, run by Assiut University.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Official record
Search all trials

Trial summary

Gastrointestinal polyps (GIPs) are unusual growths of epithelial tissue projecting from the mucosa of gastrointestinal tract (GIT) and one of the most common pathologies affecting GIT . Read more about this study

Who is it for?
Any age
Conditions the study is for
GI Cancer
How many people
130 participants
Where
No sites listed yet
Study dates
Sep 2025to Dec 2026
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • All sexes
  • No healthy volunteers
  • Child, Adult, Older adult

Study population: This cross-sectional study will be conducted on all specimens with gastrointestinal polyps referred to the pathology Laboratories at ElRajhy hospital and surgical pathology lab in Assuit University Hospital during the period from January 2022 to December 2024 after approval of the committee of ethics of scientific research in Faculty of Medicine in Assuit University. The data will be collected from registers, medical files and reports from pathological department of Assiut University Hospital.Slides will be reviewed with Haematoxylin-Eosin stain to determinethe type of the polyps.

Who may be able to join

None listed.

Who cannot join

  • Patients with insufficient data were excluded

About this study

Gastrointestinal polyps (GIPs) are unusual growths of epithelial tissue projecting from the mucosa of gastrointestinal tract (GIT) and one of the most common pathologies affecting GIT . They are either proliferative or neoplastic mucosal lesions that are commonly seen in the colon and less commonly occur in the esophagus, stomach and small intestine. They may remain asymptomatic or present as bleeding, pain and obstruction due to mass effect. However, the most important risk with the gastrointestinal polyps is the development of malignancy in some of these polyps . Gastric polyps include hyperplastic, fundic gland polyps, inflammatory fibroid polyp, adenomas like pyloric gland adenoma, and oxyntic gland adenoma. Hyperplastic gastric polyps rarely undergo neoplastic progression (1.5-2.1%) but are associated with an increased risk of synchronous cancer occurring elsewhere in the gastric mucosa . Gastric adenomas are true neoplasms and precursors of gastric cancer. Adenomas larger than 20 mm in width and villous histology have a higher risk of neoplastic progression . The presence of gastric adenomas is strongly associated with synchronous or metachronous gastric adenocarcinoma . Polyps of the small bowel are rare compared to those of the colo-rectum, with adenomas being most common and having more preference for the distal duodenum, ampullary, and periampullary region Colonic Polyps may be classified according to their gross appearance (sessile or pedunculated), histopathological features (hyperplastic, adenoma, etc.), and behavior (benign or malignant). The biggest concern is their ability to progress into adenocarcinoma, through the adenoma to carcinoma sequence due to genetic mutation .

Read the detailed description

Gastrointestinal polyps (GIPs) are unusual growths of epithelial tissue projecting from the mucosa of gastrointestinal tract (GIT) and one of the most common pathologies affecting GIT . They are either proliferative or neoplastic mucosal lesions that are commonly seen in the colon and less commonly occur in the esophagus, stomach and small intestine. They may remain asymptomatic or present as bleeding, pain and obstruction due to mass effect. However, the most important risk with the gastrointestinal polyps is the development of malignancy in some of these polyps . Gastric polyps include hyperplastic, fundic gland polyps, inflammatory fibroid polyp, adenomas like pyloric gland adenoma, and oxyntic gland adenoma. Hyperplastic gastric polyps rarely undergo neoplastic progression (1.5-2.1%) but are associated with an increased risk of synchronous cancer occurring elsewhere in the gastric mucosa . Gastric adenomas are true neoplasms and precursors of gastric cancer. Adenomas larger than 20 mm in width and villous histology have a higher risk of neoplastic progression . The presence of gastric adenomas is strongly associated with synchronous or metachronous gastric adenocarcinoma . Polyps of the small bowel are rare compared to those of the colo-rectum, with adenomas being most common and having more preference for the distal duodenum, ampullary, and periampullary region Colonic Polyps may be classified according to their gross appearance (sessile or pedunculated), histopathological features (hyperplastic, adenoma, etc.), and behavior (benign or malignant). The biggest concern is their ability to progress into adenocarcinoma, through the adenoma to carcinoma sequence due to genetic mutation . With the use of Colonoscopy as an outpatient procedure to see inside of the colon and rectum and used in screening, diagnostic and therapeutic of rectal and colon diseases It is vital to discover high-risk polyps during colonoscopy to prevent colorectal cancer. This necessitates a more comprehensive description including morphology, anatomical distribution, and histopathology of those precursor lesions within the entire colon. Among patients with sporadic colorectal polyps, it is important to identify those at risk for malignancy. According to histopathology, serrated polyps, small distal hyperplastic polyps (HPs) have no substantial malignant potential and do not affect colonoscopic surveillance intervals. However, sessile serrated lesions (SSL) and traditional serrated adenomas (TSA) increase the risk of colorectal carcinoma. Generally, high-risk adenoma refers to patients with 1 or more of the following findings: 3 or more adenomas, adenoma ≥10 mm in size, and adenoma with tubulovillous/villous or high-grade dysplasia (HGD) histology . Neoplastic polyps are accountable for roughly 5-10% of population over age of 40 and these are important predisposing factor for majority of large bowel carcinoma cases. The neoplastic polyps are of primary importance because they harbor a malignant potential, which represents a stage in the development of colorectal cancer. For this reason, it is essential to identify these polyps at a sufficiently early stage, when a simple procedure to remove them can stop the development of colorectal cancer and prevent disease and death .

Non neoplastic polyps are important differential diagnosis for the neoplastic polyps and they include: Hyperplastic polyps, Hamartomatous polyps (juvenile polyps) and inflammatory polyps (pseudopolyps). The histopathological study is essential to detect dysplasia.

Conditions
GI Cancer
Medical subject headings
Gastrointestinal Neoplasms

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. To assess the presence and grade of dysplasia either low grade or high grade dysplasia in all examined polyps.

    To assess the presence and grade of dysplasia either low grade or high grade dysplasia in all examined polyps.

    Measured: during the period from January 2022 to December 2024

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted16 Apr 2025
  2. Study startSep 2025 (estimated)
  3. Primary completionNov 2026 (estimated)
  4. Study completionDec 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Other
Time perspective
Cross-sectional
Enrolment
130 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06929117
Sponsor's protocol ID
Prevalence of GIT POlyps
Acronym
Polyp
Status last verified
Apr 2025
First submitted
8 Apr 2025
Last updated
16 Apr 2025
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

An observational study of GI Cancer, run by Assiut University.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 0 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 16 Apr 2025. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

To assess the presence and grade of dysplasia either low grade or high grade dysplasia in all examined polyps. (time frame: during the period from January 2022 to December 2024). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 16 Apr 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in